£495.00

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan

Price data last checked 150 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 16 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 319 days • 319 data points (No recent data available)

Historical
Generating forecast...
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 27 February 2025 17 May 2025 05 August 2025 23 October 2025 11 January 2026

Price Distribution

Price distribution over 319 days • 1 price levels

Days at Price
319 days 0 80 160 239 319 £495 Days at Price

Price Analysis

Most common price: £495 (319 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 319 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy for US Zip Codes
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy for US Zip Codes

£490.00 08 Jan 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in the United States
99% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in the United States

£520.00 13 Jan 2026
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
99% match

The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy

Out of Stock 17 Dec 2025
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan

£495.00 17 Apr 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Breast Cancer Screenings in China
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China

£495.00 18 Mar 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
98% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States

£520.00 20 Jan 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India

£515.00 14 Jan 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 15 Apr 2026
The 2023-2028 Outlook for Breast Cancer Screenings for US Zip Codes
98% match

The 2023-2028 Outlook for Breast Cancer Screenings for US Zip Codes

£490.00 13 Jan 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 14 Apr 2026
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
98% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 28 Mar 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 19 Apr 2026
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
98% match

The 2025-2030 World Outlook for Breast Cancer Diagnostic Products

Out of Stock 13 Jan 2026
The 2025-2030 World Outlook for Breast Cancer Screenings
98% match

The 2025-2030 World Outlook for Breast Cancer Screenings

Out of Stock 23 Jan 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products for US Zip Codes
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products for US Zip Codes

£490.00 14 Jan 2026
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
97% match

The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City

£795.00 18 Apr 2026
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments
97% match

The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments

Out of Stock 11 Feb 2026